Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis
暂无分享,去创建一个
H. Ditzel | D. Hilbert | W. Stohl | M. Schaller | V. Benoit | S. Tan | Soon-Min Tan | David M. Hilbert | Monica Schaller | Henrik J. Ditzel
[1] David Schubert,et al. Immunization with Glucose-6-Phosphate Isomerase Induces T Cell-Dependent Peripheral Polyarthritis in Genetically Unaltered Mice1 , 2004, The Journal of Immunology.
[2] Henrik J Ditzel,et al. Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis. , 2004, Arthritis and rheumatism.
[3] V. Roschke,et al. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. , 2003, Arthritis and rheumatism.
[4] R. Wait,et al. Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis. , 2003, Rheumatology.
[5] Ji-Yeon Kim,et al. Detection of antibodies against glucose 6-phosphate isomerase in synovial fluid of rheumatoid arthritis using surface plasmon resonance (BIAcore) , 2003, Experimental & Molecular Medicine.
[6] P. Robbins,et al. TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis , 2003, Annals of the rheumatic diseases.
[7] S. Tangye,et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. , 2003, The Journal of clinical investigation.
[8] V. Roschke,et al. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. , 2003, Arthritis and rheumatism.
[9] P. Schur,et al. Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. , 2003, Arthritis and rheumatism.
[10] P. Valdez,et al. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. , 2003, Immunity.
[11] X. Mariette,et al. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren’s syndrome , 2003, Annals of the rheumatic diseases.
[12] M. Corr,et al. The Role of FcγR Signaling in the K/B × N Serum Transfer Model of Arthritis1 , 2002, The Journal of Immunology.
[13] W. Stohl. B lymphocyte stimulator protein levels in systemic lupus erythematosus and other diseases , 2002, Current rheumatology reports.
[14] V. Roschke,et al. B lymphocyte stimulator protein-associated increase in circulating autoantibody levels may require CD4+ T cells: lessons from HIV-infected patients. , 2002, Clinical immunology.
[15] R. Kimberly,et al. BLyS and B cell autoimmunity. , 2002, Current directions in autoimmunity.
[16] D. Hilbert,et al. Cutting Edge: BLyS Enables Survival of Transitional and Mature B Cells Through Distinct Mediators1 , 2002, The Journal of Immunology.
[17] M. López‐Fraga,et al. APRIL modulates B and T cell immunity. , 2002, The Journal of clinical investigation.
[18] V. Morris. Primer on the Rheumatic Diseases, 12th edn. Edited by J. H. Klippel with associate editors L. L. Crawford, J. H. Stone and C. M. Weyland. £49.24. Arthritis Foundation, Atlanta, GA, USA, 2001. 700 pages. ISBN 0‐91‐242329‐3. , 2002 .
[19] L. Alfredsson,et al. Genes and environment in arthritis: can RA be prevented? , 2002, Arthritis Research.
[20] P. Jungblut,et al. Autoantibodies to GPI and creatine kinase in RA , 2002, Nature Immunology.
[21] Daniela Kassahn,et al. Few human autoimmune sera detect GPI , 2002, Nature Immunology.
[22] H. Ditzel,et al. Response to 'Autoantibodies to GPI and creatine kinase in RA' and 'Few human autoimmune sera detect GPI' , 2002, Nature Immunology.
[23] C. Benoist,et al. Arthritogenic Monoclonal Antibodies from K/BxN Mice , 2002, The Journal of experimental medicine.
[24] T. Hirano. Revival of the autoantibody model in rheumatoid arthritis , 2002, Nature Immunology.
[25] Ralph Weissleder,et al. Arthritis critically dependent on innate immune system players. , 2002, Immunity.
[26] W. Arend,et al. The innate immune system in rheumatoid arthritis. , 2001, Arthritis and rheumatism.
[27] D. Burton,et al. Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease , 2001, Nature Immunology.
[28] V. Roschke,et al. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. , 2001, Arthritis and rheumatism.
[29] G. Alarcón,et al. Cutting Edge: A Role for B Lymphocyte Stimulator in Systemic Lupus Erythematosus1 , 2001, The Journal of Immunology.
[30] J. Tschopp,et al. A Soluble Form of B Cell Maturation Antigen, a Receptor for the Tumor Necrosis Factor Family Member April, Inhibits Tumor Cell Growth , 2000, The Journal of experimental medicine.
[31] J. Tschopp,et al. Baff Mediates Survival of Peripheral Immature B Lymphocytes , 2000, The Journal of experimental medicine.
[32] Paul A. Moore,et al. Tumor Necrosis Factor (TNF) Receptor Superfamily Member TACI Is a High Affinity Receptor for TNF Family Members APRIL and BLyS* , 2000, The Journal of Biological Chemistry.
[33] M. Tourigny,et al. Attenuation of Apoptosis Underlies B Lymphocyte Stimulator Enhancement of Humoral Immune Response , 2000, The Journal of experimental medicine.
[34] Tom Boone,et al. APRIL and TALL-1 and receptors BCMA and TACI: system for regulating humoral immunity , 2000, Nature Immunology.
[35] J. Tschopp,et al. Baff Binds to the Tumor Necrosis Factor Receptor–Like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell Population , 2000, The Journal of experimental medicine.
[36] V. Dixit,et al. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI , 2000, Current Biology.
[37] Don Foster,et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease , 2000, Nature.
[38] D. Lacey,et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Tschopp,et al. Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations , 1999, The Journal of experimental medicine.
[40] C. Benoist,et al. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. , 1999, Science.
[41] Amy S Orr,et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. , 1999, Science.
[42] J. Tschopp,et al. BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth , 1999, The Journal of experimental medicine.
[43] B. Aggarwal,et al. Identification and Characterization of a Novel Cytokine, THANK, aTNF Homologue That ActivatesApoptosis, Nuclear Factor-κB, and c-Jun NH2-Terminal Kinase* , 1999, The Journal of Biological Chemistry.
[44] H. Shu,et al. TALL‐1 is a novel member of the TNF family that is down‐regulated by mitogens , 1999, Journal of leukocyte biology.
[45] A. Azzolini,et al. The influence of antibody functional affinity on the effector functions involved in the clearance of circulating immune complexes anti-BSA IgG/BSA. , 1999, Immunological investigations.
[46] D. Pot,et al. Characterization of a New Member of the TNF Family Expressed on Antigen Presenting Cells , 1999, Biological chemistry.
[47] J. Tschopp,et al. APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth , 1998, The Journal of experimental medicine.
[48] G. Korbutt,et al. Anti-BSA antibodies do not cross-react with the 69-kDa islet cell autoantigen ICA69. , 1998, Journal of autoimmunity.
[49] M. Rowley,et al. IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases. , 1997, The Journal of rheumatology.
[50] P. Czernichow,et al. Antibodies Against Bovine Albumin and Other Diabetes Markers in French Children , 1995, Diabetes Care.
[51] M. Corbett,et al. Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: prevalence, clinical correlates, and IgG subclass. , 1994, Annals of the rheumatic diseases.
[52] J. Ilonen,et al. A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. , 1992 .
[53] G. Kingsley,et al. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. , 1992, Arthritis and rheumatism.
[54] C. Bernabéu,et al. Antibodies to dietary antigens in rheumatoid arthritis--possible molecular mimicry mechanism. , 1991, Clinica chimica acta; international journal of clinical chemistry.
[55] J. J. Bunim,et al. Primer on the rheumatic diseases. , 1949, Journal of the American Medical Association.
[56] G. Panayi,et al. Autoantigens and immune pathways in rheumatoid arthritis. , 2002, Critical reviews in immunology.
[57] M. Corr,et al. The role of FcgammaR signaling in the K/B x N serum transfer model of arthritis. , 2002, Journal of immunology.
[58] J. Tschopp,et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. , 2002, The Journal of clinical investigation.
[59] P. Moore,et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. , 2001, Blood.
[60] J. Zabriskie,et al. Detection of antibodies against streptococcal peptidoglycan and the peptide subunit (synthetic tetra-D-alanyl-bovine serum albumin complex) in rheumatic-diseases. , 1992, International archives of allergy and immunology.